FDA grants breakthrough designation to Vaxcyte’s VAX-24 for IPD prevention
The FDA designation for the 24-valent PCV vaccine candidate was based on positive topline data results from a…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Jan 23
The FDA designation for the 24-valent PCV vaccine candidate was based on positive topline data results from a…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 Jan 23
Just Like Sour Cream pairs well with Violife's dairy-free cheese varieties, making it easier than ever for consumers…
05 Jan 23
Offering a new way to enjoy made-to-order, freshly blended fruit and vegetable smoothies through contactless and customized ordering,…
05 Jan 23
"We are excited to partner with Welch's on their jams and jellies that are so well-loved by Americans,"…
05 Jan 23
"The Convergence Accelerator is a relatively young NSF program, but our unique program model is focused on delivering…
05 Jan 23
The acquisition is expected to support Moderna’s suite of platform technologies, and OriCiro’s synthetic biology and enzyme technologies…
05 Jan 23
The Chinese CRDMO will grant GSK a licence for one preclinical bi-specific T cell engaging antibody and the…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
04 Jan 23
Gilead will obtain an option to licence EVOQ’s nanodisc technology and exclusive rights to develop and commercialise immunotherapy…
04 Jan 23
The patent protects against compounded, unapproved copies of Mitosol, the company's flagship medication, in future applications
03 Jan 23
Sandoz will acquire the global rights to ALT-B4, derived using Alteogen’s Hybrozyme technology, to develop a subcutaneous version…